Pipeline Therapeutics will initiate a Phase II trial of its remyelination drug in multiple sclerosis (MS) by the end of...
Read More...
The post Pipeline Therapeutics to start Phase II multiple sclerosis trial appeared first on Pharmaceutical Technology.
Original Article: Pipeline Therapeutics to start Phase II multiple sclerosis trial